Evolent Health financials at a glance

+ Portfolio

The revenue of Evolent Health is reported as 1.9639 billion Dollars in the fiscal year 2023. The earnings were 0.87 Dollars per share in 2023, which was 8.42 lower than 2022. And about 0.11383 billion Dollars are reported as free cash flow in the financials of Evolent Health 2023. No dividends were paid to the shareholders of the Evolent Health stock NYSE:EVH in the financial year 2023.

$1.96B

Revenue

$0.87

Earnings Per Share

23.45%

Gross Margin %

$72.80M

Free Cash Flow

Revenue

1,963.90

Earnings Per Share

0.87

Gross Margin %

23.45

Free Cash Flow

72.80

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	$1.96B	$1.35B	$907.96M	$1.02B	$846.38M	$627.06M	$434.95M	$256.28M	$163.52M
GM %	Gross Margin %	24.68%	23.45%	23.42%	27.58%	22.80%	23.34%	36.42%	38.07%	40.05%	40.75%
OM	Operating Margin	1.22%	1.57%	0.37%	-1.92%	-3.98%	-12.17%	-7.52%	-14.24%	-24.84%	-39.92%
EPS	Earnings Per Share	$-1.04	$0.87	$0.95	$0.02	$-0.21	$-0.72	$-0.12	$-0.35	$-0.57	$-0.94
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0.00%	0	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	113.89M	109.51M	89.29M	86.09M	84.72M	79.38M	74.78M	52.61M	42.56M
OCF	Operating Cash Flow	N/A	$142.58M	$-11.55M	$38.75M	$-16.23M	$-42.65M	$-20.65M	$-27.96M	$-35.51M	$-19.83M
FCF	Free Cash Flow	N/A	$72.80M	$-49.91M	$13.76M	$-45.70M	$-78.18M	$-60.20M	$-55.81M	$-51.04M	$-24.98M
FCFS	Free Cash Flow Per Share	$-3.24	$0.85	$-3.28	$0.13	$-0.57	$-1.05	$-0.79	$-0.92	$-1.39	$-0.99

Evolent Health financials at a glance

Financials

Discover